Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today issued a letter to its shareholders in connection with the Company's upcoming 2023 Annual...

Related Keywords

Iron Mountain ,New York ,United States ,Dublin ,Ireland ,Ohio ,Athlone ,Westmeath ,Massachusetts ,Canada ,Innisfree ,Sligo ,Waltham ,Irish ,Davida Daglio ,Wilda Van Dusen ,W Montague Cobb ,Nancyj Wysenski ,Eli Lilly ,Shanem Cooke ,Emily Peterson ,Andy Wilson ,Richard Gaynor ,Katie Joyce ,Catot Laurencin ,Frank Anders Wilson ,Alexander Denner ,Sarahj Schlesinger ,Nancyl Snyderman ,America Ph ,David Daglio ,Christopher Wright ,Shane Cooke ,Sarah Schlesinger ,Brianp Mckeon ,Alexj Denner ,Cato Laurencin ,Chris Kittredge Zachary Tramonti ,Patrice Bonfiglio ,Brian Mckeon ,Emily Peterson Alva ,Richardb Gaynor ,Christopheri Wright ,Nancy Wysenski ,Professor Of Neurology At Harvard Medical School ,Pembroke Capital ,Clinical Development ,Neon Therapeutics Inc ,Africana Studies Institute ,Infinity Pharmaceuticals Inc ,Catot Laurencin Institute For Regenerative Engineering ,Emergent Biosolutions Inc ,Prothena Corporation ,Biotechnology Innovation Organization ,Acadia Pharmaceuticals Inc ,University Of Connecticut Uconn ,Elan Corporation ,Leap Therapeutics Inc ,Health Institute ,Mimedx Group Inc ,Company Annual Report On Form ,Affairs Of Lilly Oncology ,Vertex Pharmaceuticals Incorporated ,Corporate Governance Committee ,Axcella Health Inc ,Lazard ,Laboratories Inc ,Harvard Medical School Board Of Fellows ,Aavantibio Inc ,Acceleron Pharma Inc ,Jazz Pharmaceuticals ,Exelixis Inc Incyte Corporation ,School Of Medicine ,Sage Therapeutics Inc ,Head Of Translational Research Ring Therapeutics ,Damon Runyon Cancer Research Foundation ,United Therapeutics Corporation ,Sarepta Therapeutics Inc ,Mission Society Of New York City ,Ultragenyx Pharmaceutical Inc ,Pepsico Inc ,National Health Council ,Therapeutics Inc ,Zai Lab ,Alnylam Pharmaceuticals Inc ,Company Or Alkermes ,University Professor ,Ethnic Health Disparities ,Global Medicines Development ,Endo International ,Neurocrine Biosciences Inc ,Biontech Us Inc ,Ironwood Pharmaceuticals Inc ,Cyclerion Therapeutics Inc ,Epizyme Inc ,Timberland Company ,Nasdaq ,Iron Mountain Incorporated ,Denner ,Nominees On Company ,Ionis Pharmaceuticals Inc ,Exchange Commission ,Blueprint Medicines Corporation ,Alkermes ,Innisfree Ma Incorporated ,Amneal Pharmaceuticals Inc ,Shareholders Vote ,Director Nominees ,General Meeting ,Annual Meeting ,Alkerme Value Enhancement Plan ,Sarissa Capital Management ,Richard Pops ,Alkermes Shareholder ,Value Enhancement Plan ,Annual General Meeting ,Elliott Management ,Lead Independent ,Key Roles ,Advisory Experience ,Amneal Pharmaceuticals ,Emission Society ,New York City ,Elan Drug Technologies ,Executive Vice President ,Chief Financial Officer ,Chief Executive ,Pembroke Capital Limited ,Neon Therapeutics ,Senior Vice President ,Medical Affairs ,Lilly Oncology ,Simmons Cancer Center ,Texas Southwestern Medical School ,Infinity Pharmaceuticals ,Zai Lab Limited ,Leap Therapeutics ,Wilda Van Dusen Distinguished Endowed Professor ,Orthopaedic Surgery ,Biomolecular Engineering ,Materials Science ,Biomedical Engineering ,Chief Executive Officer ,Regenerative Engineering ,Founding Chair ,Mimedx Group ,Vice President ,North America ,Prescription Drug User Fee Act ,Polaris Venture Partners ,Harvard Medical School Board ,Neurocrine Biosciences ,Pharmaceutical Research ,Acceleron Pharma ,Chief Medical Officer ,Translational Research ,Ring Therapeutics ,Cyclerion Therapeutics ,Chief Development Officer ,Ironwood Pharmaceuticals ,Axcella Health ,Associate Professor ,Harvard Medical School ,Scientific Advisor ,Interactions Between Sarissa ,Alkermes Independent Directors ,Lead Independent Director Nancy Wysenski ,Sarissa Designee ,Sarissa Nominees ,Chief Investment Officer ,Current Refreshed Board ,Not Truly Independent ,Current Refreshed ,Alkerme Board ,Alkermes Board ,Private Securities Litigation Reform Act ,Annual Report ,Additional Information ,Alnylam Pharmaceuticals ,Incyte Corporation ,Ionis Pharmaceuticals ,Sage Therapeutics ,Sarepta Therapeutics ,United Therapeutics ,